Cortica
PrivateLast Round
Strategic
Nov 20, 2024
Total Funding Raised
$295M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Cortica operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Strategic round in November 2024.
Cortica is a healthcare company that provides comprehensive, physician-led, whole-child care for children with autism and other neurodevelopmental disorders through an integrated model of medical, behavioral, and developmental therapies.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Telemedicine, Patient Engagement, Healthcare Analytics
Business Model
B2B2C
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cortica Comparables
Compare Cortica with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hopebridge Autism Therapy Centers | 86% | |
| Lighthouse Autism Center | 84% | |
| Acorn Health | 82% |
For institutional investors. Book with your work email.
Cortica Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Nov 20, 2024 | ||||
| Series D Extension | Oct 3, 2023 | ||||
| Series D | Apr 18, 2023 | ||||
| Strategic | Apr 20, 2022 | ||||
| Series C | Jun 29, 2021 | ||||
Strategic | Dec 31, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cortica Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series D, Series C |
| Deerfield Management | Series D |
| RA Capital Management | Series D |
| Aetna Ventures | Series D Extension |
| Ajax Health | Series D, Strategic |
| Questa Capital | Series C, Strategic, VC Round, Series D |
| Nexus NeuroTech Ventures | Strategic |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 24, 2026
Received a 4.0 rating on Indeed for 2025.
- Jun 24, 2026
Received a 4.1 rating on Glassdoor.
For institutional investors. Book with your work email.
Cortica Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cortica's valuation, stock price, and market status.
Is Cortica a public or private company?
Cortica is a private company.
What is the current stock price of Cortica?
Cortica is a private company, so its shares have no public market price. Caplight tracks Cortica's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cortica worth (valuation)?
Valuation information for Cortica is not publicly available.
Can I buy Cortica stock?
Cortica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cortica's last funding round?
Cortica's most recent funding round was Strategic on November 20, 2024.
Who are the main investors in Cortica?
Key investors in Cortica include Longitude Capital, Deerfield Management, Aetna Ventures, Ajax Health, Questa Capital.
Will Cortica IPO soon?
No public IPO plans have been announced for Cortica.
How can I track Cortica secondary market activity?
Caplight tracks bids, offers, and trades in Cortica's shares on secondary markets.